Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
JW Pharmaceutical clinical trials
Also known as Choongwae.
Part of JW Holdings, which holds 44.61% as of 2025-12-31. Source
The registry lists 77 studies whose lead sponsor is JW Pharmaceutical. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 13, 2026.
Keep track of what changes. Save the JW Pharmaceutical studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to JW Pharmaceutical.
- JW Pharmaceutical77 studiesSame company
Something wrong?
Focus areas
Conditions JW Pharmaceutical leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 77. Browse all 77 →
- to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and MenorrhagiaRecruitingNCT07378098Phase 3
- To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy VolunteersRecruitingNCT07514780Phase 1
- Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational StudyRecruitingNCT07523971
- Glycemic Variability of Combination Therapies in T2DMRecruitingNCT07442006Phase 4
- Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and DyslipidemiaRecruitingNCT06643130Phase 3
- To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy VolunteersRecruitingNCT06703710Phase 1
- To Evaluate the Safety and Pharmacokinetic Characteristics in Healthy VolunteersCompletedNCT07374406Phase 1
- A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout PatientsCompletedNCT05815901Phase 3
- To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male SubjectsCompletedNCT07036458Phase 1
- PK,PD and DDI of Epaminurad and C2406 in Healthy VolunteersCompletedNCT06665425Phase 1
- PK,PD and DDI of Epaminurad and Naproxen in Healthy VolunteersCompletedNCT06435442Phase 1
- Efficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimibe in Patients With HypercholesterolemiaCompletedNCT07445542
- Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated TriglyceridesActive, not recruitingNCT07442630Phase 4
- Efficacy and Safety of Livalozet® in Hypercholesterolemic Patients With and Without DiabetesCompletedNCT07382778
- Clinical Study of CWP232291 in Acute Myeloid Leukemia PatientsTerminatedNCT03055286Phase 1/2
- To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With T2DMCompletedNCT05814406Phase 3
- To Evaluate the Safety and PK Characteristics After Co-administration of JW0104 and C2402 and Administration of JW0105CompletedNCT06754943Phase 1
- To Evaluate the Safety and PK Characteristics in Healthy Volunteers-LivalozetCompletedNCT01764178Phase 1
- To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes MellitusCompletedNCT05814393Phase 3
- Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With DyslipidemiaCompletedNCT06955104Phase 3
- To Evaluate the Safety and PK Characteristics in Healthy Volunteers-JW24107CompletedNCT06816719Phase 1
- Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic DermatitisCompletedNCT05117060Phase 2
- A Trial to Evaluate the Effect of LEO 152020 on the Heart of Healthy PeopleCompletedNCT05508776Phase 1
- Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic UrticariaCompletedNCT04853992Phase 2
- A Trial to Evaluate the Effect of Food on LEO 152020CompletedNCT04203836Phase 1
- To Evaluate the Safety and Pharmacokinetic Interactions in Healthy VolunteersCompletedNCT06378684Phase 1
- To Evaluate the Pharmacokinetic Characteristics and Safety in Healthy VolunteersCompletedNCT06361277Phase 1
- To Evaluate the Safety and PK Characteristics in Healthy VolunteersCompletedNCT06355349Phase 1
- To Evaluate the PK, PD, Safety and Drug Tolerance in Healthy VolunteersCompletedNCT05433844Phase 1
- To Evaluate the PK, PD, Safety and Drug Tolerance of JW0302 in Healthy VolunteersCompletedNCT05784155Phase 1
- To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and HypertensionCompletedNCT05331014Phase 3
- A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal ImpairmentCompletedNCT05198778Phase 1
- To Evaluate the Pharmacokinetic Interactions and Safety in Healthy VolunteersCompletedNCT05351840Phase 1
- To Evaluate the Pharmacokinetic Drug Interactions, Safety and Drug Tolerance in Healthy VolunteersCompletedNCT05463497Phase 1
- Efficacy and Safety Study of Pitavastatin Versus Atorvastatin to Treat HypercholesterolemiaCompletedNCT01166633Phase 4
- To Evaluate the Efficacy and Safety in Patients With Primary HypercholesterolemiaCompletedNCT04584736Phase 3
- The Safety of Emicizumab SC Injection in Korean Hemophilia A Patients With/Without FVIII InhibitorsStatus unknownNCT04805801
- Korean Observational Study to Evaluate the Efficacy and Safety of Anagliptin Switching From Other DPP4is in type2 DMStatus unknownNCT04267601
- Efficacy and Safety of Pitavastatin in a Real-world SettingCompletedNCT04402112
- The Occurrence of MACE in Patients With AMI Receiving Pitavastatin/Valsartan TreatmentStatus unknownNCT04270344
- Registry Study of ID & IDA in Korean Patients With Heart FailureCompletedNCT04812873
- MAGE of Anagliptin Compared With Sitagliptin With Type 2 Diabetes MellitusCompletedNCT04810507Phase 4
- A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis.CompletedNCT04027517Phase 3
- Study of of URC102 to Assess the Efficacy and Safety in Gout PatientsCompletedNCT04804111Phase 2
- Single and Multiple Ascending Dose Study of JW1601 for Healthy VolunteersCompletedNCT04018170Phase 1
- Phase 1 Study(Additional) of URC102 in Healthy SubjectsCompletedNCT02524678Phase 1
- Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With HypercholesterolemiaCompletedNCT00889226Phase 4
- Clinical Study of CWP232291 in Relapsed or Refractory Myeloma PatientsCompletedNCT02426723Phase 1
- Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular SystemCompletedNCT02029560
- to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and HyperlipidemiaCompletedNCT02056847Phase 4